News | Computed Tomography (CT) | August 15, 2022

Combo of deep-learning reconstruction and subtraction technique yielded optimal diagnostic performance for the detection of in-stent restenosis by coronary CTA 

57-year-old man who underwent coronary CTA using two-breath-hold subtraction technique to assess patency of coronary artery stent.

A. Conventional HIR image and B. conventional DLR image show blurred appearance of proximal aspect of stent (arrow). C. Subtraction HIR image and D. subtraction DLR image show discrete region of hypoattenuation at proximal aspect of stent (arrow). Both readers provided a diagnosis of in-stent restenosis only for subtraction HIR and subtraction DLR. Diagnostic confidence score for the four methods for reader 1 was 2, 2, 3, and 4, respectively, and for reader 2 was 1, 2, 3, and 3, respectively. Patient subsequently underwent invasive catheter angiography. Fluoroscopic imagines obtained (E) before and (F) after contrast media injection demonstrate in-stent restenosis of proximal aspect of stent (arrow). Image courtesy of ARRS and AJR 


August 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the combination of deep-learning reconstruction (DLR) and a subtraction technique yielded optimal diagnostic performance for the detection of in-stent restenosis by coronary CTA. 

Noting that these findings could guide patient selection for invasive coronary stent evaluation, combining DLR with a two-breath-hold subtraction technique “may help overcome challenges related to stent-related blooming artifact,” added corresponding author Yi-Ning Wang from the State Key Laboratory of Complex Severe and Rare Diseases at China’s Peking Union Medical College Hospital. 

Between March 2020 and August 2021, Wang and team studied 30 patients (22 men, 8 women; mean age, 63.6 years) with a total of 59 coronary stents who underwent coronary CTA using the two-breath-hold technique (i.e., noncontrast and contrast-enhanced acquisitions). Conventional and subtraction images were reconstructed for hybrid iterative reconstruction (HIR) and DLR, while maximum visible in-stent lumen diameter was measured. Two readers independently evaluated images for in-stent restenosis (≥50% stenosis). 

Ultimately, coronary CTA using DLR and subtraction technique—with a combined (conventional and subtraction images) interpretation—yielded PPV, NPV, and accuracy for in-stent restenosis for reader 1 of 73.3%, 93.2%, and 88.1%, and for reader 2 of 75.0%, 84.3%, and 83.1%, respectively. 

Acknowledging that the two-breath-hold subtraction technique requires an additional noncontrast acquisition (and thus a higher radiation dose), “DLR allows a reduction in radiation exposure, while improving image quality,” the authors of this AJR article pointed out

For more information: www.arrs.org 


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Radiology Imaging

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now